Home › Compare › GUOSF vs ABBV
GUOSF yields 3.00% · ABBV yields 3.06%● Live data
📍 GUOSF pulled ahead of the other in Year 3
Combined, GUOSF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GUOSF + ABBV for your $10,000?
Guotai Junan Securities Co., Ltd. provides various financial services for individuals and institutional clients in Mainland China, Hong Kong, and internationally. It operates through Wealth Management Business, Investment Banking Business, Institutional and Trading Business, Investment Management Business, and International Business segments. The company offers securities and futures brokerage, financial products, investment advisory, margin financing and securities lending, securities repurchase, and stock pledging and other services; listing sponsorship, equity underwriting, debt underwriting, structured debt financing, M&A financial advisory, and diversified corporate solutions to corporate and governmental clients; institutional brokerage, trading, investment and equity investment, seat leasing, custody and outsourcing, QFII, and other services; and investment transactions in stocks, fixed income, foreign exchange, and commodities and their derivative financial instruments, as well as integrated financial solutions for clients' investment, financing, and risk management. It also provides asset management and fund management services; and brokerage, corporate finance, asset management, and loans and financing services, as well as financial products, and market making and investment services. In addition, the company offers real estate and property management, warehouse service, corporate management consulting, venture capital investment and management, investment management, industrial investment, and investment consulting services. The company was founded in 1992 and is based in Shanghai, China.
Full GUOSF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.